Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway

Fig. 6

Silencing miR-127-3p expression reversed effect of cotreatment with diallyl thiosulfinate and dexamethasone (DATS+Dex) on proliferation of multiple myeloma (MM) side population (SP) cells. a miR-127-3p expression was inhibited in cells transfected with miR-127-5p. b Proliferation of MM SP cells detected using MTS analysis at 0, 24, 48, 72 h after treatment. Silencing miR-127-3p expression promoted proliferation of MM SP cells cotreated with DATS+Dex. ***P < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us